Booking Holdings has cleared its June 2 earnings event with short sellers already trimming — and the question now shifts from "what happens at the print" to "where does the stock go from $167."
The most notable development this week is the partial unwind of the short book built up since late April. Short interest against the free float has fallen roughly 6.5% over the past week to 79.8% — wait, that figure warrants a data-consistency flag. The snapshot reports percent_of_float at ~79.8%, which appears to reflect a float calculation anomaly rather than genuine short positioning; the prior note from May 27 cited the level as ~3.55% of float with 27.4 million shares short, and this week's 25.7 million shares short is consistent with a modest unwind from that base. Taking the share count at face value, shorts have pulled back roughly 1.8 million shares from their late-May peak near 27.5 million — a clear post-earnings trim, not a full exit. The ORTEX short score has nudged slightly lower to 35.4 from 35.9 a week ago, consistent with modest pressure coming off.
The borrow market tells a similarly relaxed story. Availability is extraordinarily loose — nearly 6,000% — meaning there are roughly sixty shares available to borrow for every one currently shorted. That is well above even the already-elevated levels seen in the previous note. Cost to borrow has edged up about 11% on the week to 0.52% annualised, but that remains firmly in negligible territory. Options positioning is equally unmoved: the put/call ratio of 0.785 is essentially flat against its 20-day average of 0.784, with a z-score barely above zero. There is no meaningful hedging or directional signal in the derivatives market right now.
The Street kept its convictions after the print but trimmed its price tags. The bulk of the post-earnings analyst activity came on April 29 — JPMorgan's Doug Anmuth cut his target from $224 to $208 while holding Overweight; UBS, TD Cowen, RBC, Citi, Oppenheimer and Evercore all maintained positive ratings while nudging targets lower by $10–25. The consensus remains constructive: nearly every active coverage name is at Buy or Outperform, and the mean target of around $224 implies roughly 34% upside to the current $167 print. BTIG reiterated its $250 Buy on May 29, the most recent action, providing a fresh data point that the bull camp has not abandoned the stock. Bulls point to Booking's dominant global travel platform, resilient non-Middle East bookings, and EBITDA execution. Bears flag SEO headwinds, competitive pressure from Airbnb and Trip.com, and a consumer spending outlook that keeps targets from moving higher. The P/E multiple near 14.9x and EV/EBITDA of 11.5x are not stretched for a company with this earnings track record — the EPS surprise factor score ranks in the 79th percentile — but the 90-day EPS momentum score has collapsed to the 3rd percentile, signalling that forward estimates have been revised sharply lower.
Insider activity adds a cautionary note at the margin. General Counsel Peter Millones sold approximately $10.2 million in stock across four transactions on May 26, the largest insider disposal in recent weeks. CFO Ewout Steenbergen sold roughly $1.97 million on May 12. CEO Glenn Fogel sold around $2.2 million across several lots in mid-April. All three are sell-only flows, and while executive stock sales are frequently plan-driven, the clustering across multiple C-suite names in a six-week window at prices well above current levels ($157–$192 versus today's $167) at least confirms that no senior insider was buying the dip.
Among close peers, EXPE fell 0.9% on the day and gained 1.5% on the week — roughly in line with BKNG's own 2.4% weekly gain. ABNB was weaker, down 2.6% Tuesday and up just 1.3% on the week. DASH led the downside with a 4.75% single-day drop. The travel group broadly recovered from its May lows but has not regained momentum, and BKNG is tracking close to the middle of the pack.
The next earnings event is July 30. Between now and then, the stock's trajectory will likely hinge on whether those analyst target cuts prove conservative or prescient — with the stock trading at a 25% discount to the consensus mean target, the gap is wide enough to matter when the next quarterly data lands.
See the live data behind this article on ORTEX.
Open BKNG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
